Table 1.
Characteristics | Baseline (May 2017–September 2019) |
2-year follow-up (May 2019–September 2021) |
4-year follow-up (May 2021–September 2023) |
Written informed consent | X | ||
Demographics and socioeconomic status | X | ||
Medical history | X | ||
Family history | X | ||
Diet and lifestyle assessment | X | ||
Physical examination | X | ||
ECG | X | ||
Echocardiography | X | ||
Fundus fluorescein photography | X | ||
Ankle brachial index | X | ||
Medications | X | X | X |
Blood and urine sample | X | X | X |
CTA scanning | X | X | |
MRI scanning | X | X | X |
Cognitive assessment | X | X | X |
Vascular events | X | X |
CTA, CT angiography; PRECISE, PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events.